{"product_id":"peptide-synthesis-market-by-reagents-resins-amino-acid-dyes-equipment-peptide-synthesizer-chromatography-lyophilizer-technology-solid-phase-solution-phase-hybrid-services-end-user-pharma-biotech-cro-region-global-forecast-to-2028","title":"Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid), Services, End User (Pharma, Biotech, CRO), Region - Global Forecast to 2028","description":"\u003cp\u003ePeptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid), Services, End User (Pharma, Biotech, CRO), Region - Global Forecast to 2028\u003c\/p\u003e\n\n\u003cp\u003eThe global peptide synthesis market size is projected to reach USD 859 million by 2028 from 601 million in 2023, at a CAGR of 7.4 % during the forecast period. Factors such advancement in the field of peptide synthesis, and increased demand for reagents used in peptide synthesis is expected to experience steady growth leading to positive impact on the growth of peptide synthesis products \u0026amp; services.\u003c\/p\u003e\n\n\u003cp\u003e“The reagents segment accounted for the highest growth rate in the peptide synthesis market, by product \u0026amp; service, during the forecast period”\u003c\/p\u003e\n\n\u003cp\u003eIn 2022, the reagents segment accounted for the highest growth rate. The peptide synthesis reagents market is further segmented into resins, amino acids, coupling reagents, dyes and fluorescent labeling reagents, and other reagents (such as protecting reagents, linkers, buffers, solvents, and solutions). The requirement of reagents in bulk quantities, expanding applications of peptides in therapeutics, drug design, and gene synthesis are some of the factors anticipated to project the growth of the segment.\u003c\/p\u003e \n\n\u003cp\u003e“Asia Pacific region is likely to grow at a faster pace.”\u003c\/p\u003e\n\n\u003cp\u003eThe peptide synthesis market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East \u0026amp; Africa. In 2022, North America accounted for the dominant share of the peptide synthesis market. The dominance of the region is attributable to various factors such as the presence of leading players in the region coupled with the ongoing research activities of developing new targeted therapies. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing awareness of personalized therapeutics, rising government initiatives for generic medicines in the region, and the emergence of new market players in the peptide synthesis market.\u003c\/p\u003e \n\n\u003cp\u003eThe primary interviews conducted for this report can be categorized as follows:\u003c\/p\u003e\n\n\u003cp\u003eBy Respondent: Supply Side- 70%, and Demand Side - 30%\u003c\/p\u003e\n\n\u003cp\u003eBy Designation (Supply Side): Managers - 45%, CXOs \u0026amp; Directors - 30%, Executives- 25%\u003c\/p\u003e\n\n\u003cp\u003eBy Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%\u003c\/p\u003e\n\n\u003cp\u003eLists of Companies Profiled in the Report:\u003c\/p\u003e\n\n\u003cp\u003eBachem Holding AG (Switzerland)\u003c\/p\u003e\n\n\u003cp\u003eThermo Fisher Scientific, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eMerck KGaA (Germany)\u003c\/p\u003e\n\n\u003cp\u003eGenScript Biotech Corporation (China)\u003c\/p\u003e\n\n\u003cp\u003eKaneka Corporation (Japan)\u003c\/p\u003e\n\n\u003cp\u003eBiotage AB (Sweden)\u003c\/p\u003e\n\n\u003cp\u003eSyngene International Ltd. (India)\u003c\/p\u003e\n\n\u003cp\u003eMesa Laboratories Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eCEM Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eProteoGenix (France)\u003c\/p\u003e\n\n\u003cp\u003eBio-Synthesis Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eDalton Pharma Services (Canada)\u003c\/p\u003e\n\n\u003cp\u003eAAPPTec (US)\u003c\/p\u003e\n\n\u003cp\u003evivitide (US)\u003c\/p\u003e\n\n\u003cp\u003eAnyGen Co., Ltd. (South Korea)\u003c\/p\u003e\n\n\u003cp\u003eCSBio (US)\u003c\/p\u003e\n\n\u003cp\u003eAdvanced Chemtech (US)\u003c\/p\u003e\n\n\u003cp\u003eLuxembourg Bio Technologies Ltd. (Israel)\u003c\/p\u003e\n\n\u003cp\u003eJPT Peptide Technologies GmbH (Germany)\u003c\/p\u003e\n\n\u003cp\u003eAmbioPharm Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eAurigene Pharmaceutical Services Ltd. (India)\u003c\/p\u003e\n\n\u003cp\u003eCorden Pharma International (Germany)\u003c\/p\u003e\n\n\u003cp\u003eChemPep Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eCPC Scientific Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003ePurolite Pvt Ltd. (US)\u003c\/p\u003e\n\n\u003cp\u003eResearch Coverage:\u003c\/p\u003e\n\n\u003cp\u003eThis report provides a detailed picture of the peptide synthesis market. It aims at estimating the size and future growth potential of the market across different segments, such the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.\u003c\/p\u003e\n\n\u003cp\u003eKey Benefits of Buying the Report:\u003c\/p\u003e\n\n\u003cp\u003eThe report will help market leaders\/new entrants by providing them with the closest approximations of the revenue numbers for the overall peptide synthesis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.\u003c\/p\u003e\n\n\u003cp\u003eThe report provides insights on the following pointers:\u003c\/p\u003e \n\n\u003cp\u003eAnalysis of key drivers (the increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R\u0026amp;D, and the development of advanced automated peptide synthesizers), restraints (Lack of a unified set of regulations for therapeutic peptides, High cost of instruments), opportunities (Emerging markets in the Asia Pacific region, Development of personalized medicines), and challenges (Issues associated with the route of administration of peptide drugs, Addressing environmental impact of chemical synthesis of peptides.)\u003c\/p\u003e\n\n\u003cp\u003eProduct \u0026amp; Service Development\/Innovation: Detailed insights on newly launched products, and technological assessment of the peptide synthesis market.\u003c\/p\u003e\n\n\u003cp\u003eMarket Development: Comprehensive information about lucrative markets – the report analyses the peptide synthesis market across varied regions.\u003c\/p\u003e \n\n\u003cp\u003eMarket Diversification: Exhaustive information about new products \u0026amp; services, untapped geographies, recent developments, and investments in the peptide synthesis market.\u003c\/p\u003e \n\n\u003cp\u003eCompetitive Assessment: In-depth assessment of market shares, growth strategies, and product \u0026amp; service offerings of leading players like GenScript Biotech Corporation (China), Thermo Fisher Scientific, Inc. (US), Bachem Holding AG (Switzerland), Kaneka Corporation (US), Inc.and Merck KGaA (Germany) and among others in the peptide synthesis market.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 248 Pages \/ MCW16231166","offer_id":47647273877810,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/peptide-synthesis-market-by-reagents-resins-amino-acid-dyes-equipment-peptide-synthesizer-chromatography-lyophilizer-technology-solid-phase-solution-phase-hybrid-services-end-user-pharma-biotech-cro-region-global-forecast-to-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}